Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AARRIVENT BIOPHARMA, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

ARRIVENT BIOPHARMA, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Jun 18, 2026Nolet ChrisDirector13,562Non-Qualified Stock Option (right to buy)$430.5KGrant / award
Jun 18, 2026Hohneker JohnDirector13,562Non-Qualified Stock Option (right to buy)$430.5KGrant / award
Jun 18, 2026Peterson KristineDirector13,562Non-Qualified Stock Option (right to buy)$430.5KGrant / award
Jun 18, 2026Parsey MerdadDirector13,562Non-Qualified Stock Option (right to buy)$430.5KGrant / award
Feb 2, 2026Kastenmayer James PaulGeneral Counsel130,000Stock Option (right to buy)$2.9MGrant / award
Feb 2, 2026Yao ZhengbinPresident and CEO550,000Stock Option (right to buy)$12.4MGrant / award
Feb 2, 2026Kung WinstonChief Financial Officer140,000Stock Option (right to buy)$3.1MGrant / award
Feb 2, 2026Lutzker StuartPresident of R&D150,000Stock Option (right to buy)$3.4MGrant / award
Feb 2, 2026LaChapelle RobinChief Operating Officer130,000Stock Option (right to buy)$2.9MGrant / award
Dec 10, 2025HILLHOUSE INVESTMENT MANAGEMENT, LTD.10% Owner555,555Common Stock$13.7MSell
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
$16.89Close ยท Oct 7, 2026